These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 4305038

  • 1. [Studies on additional Iscador therapy in the management of women with surgically and radiotherapeutically treated genital carcinoma].
    Leroi R.
    Gynaecologia; 1969; 167(3):158-70. PubMed ID: 4305038
    [No Abstract] [Full Text] [Related]

  • 2. [After care of irradiated genital carcinoma using the Viscum album preparation Iscador for the prevention of recurrences].
    Fellmer KE.
    Med Klin; 1967 Feb 24; 62(8):305-7. PubMed ID: 4297248
    [No Abstract] [Full Text] [Related]

  • 3. Chemotherapy in gynecologic cancer.
    Savage EW, Maidman JE.
    Obstet Gynecol Annu; 1976 Feb 24; 5():339-430. PubMed ID: 185550
    [No Abstract] [Full Text] [Related]

  • 4. [Resistance formation in the cytostatic treatment of carcinomas].
    Heckmann U, Tranckjer AS, Harms J.
    Zentralbl Gynakol; 1969 Sep 13; 91(37):1204-10. PubMed ID: 5368211
    [No Abstract] [Full Text] [Related]

  • 5. [New viewpoints on using anabolic steroids in gynecologic radiotherapy, including animal experimental studies in healthy and tumor-vaccinated mice and rats].
    Picha E.
    Strahlentherapie; 1969 Sep 13; 138(3):300-22. PubMed ID: 5349536
    [No Abstract] [Full Text] [Related]

  • 6. [Cytostatic treatment of genital carcinoma].
    Limburg H.
    Zentralbl Gynakol; 1969 Sep 13; 91(37):1193-203. PubMed ID: 4983833
    [No Abstract] [Full Text] [Related]

  • 7. Cancer treatment with sulfones.
    Graham J, Graham R.
    Surg Gynecol Obstet; 1969 Jul 13; 129(1):103-7. PubMed ID: 5790690
    [No Abstract] [Full Text] [Related]

  • 8. Current status of chemotherapy in gynecologic cancer.
    Tropé C, Kristensen G.
    Semin Oncol; 1997 Oct 13; 24(5 Suppl 15):S15-1-S15-22. PubMed ID: 9346216
    [No Abstract] [Full Text] [Related]

  • 9. [Possibilities of drug therapy of gynecologic malignancies].
    Armborst V.
    Med Welt; 1967 Oct 21; 42():2498-501. PubMed ID: 4306391
    [No Abstract] [Full Text] [Related]

  • 10. The use of cytotoxic chemotherapy in conjunction with gynaecological surgery.
    Guthrie D.
    Clin Obstet Gynaecol; 1978 Dec 21; 5(3):709-27. PubMed ID: 367674
    [No Abstract] [Full Text] [Related]

  • 11. Palliation chemotherapy of pelvic carcinoma by systemic, perfusion, and infusion modalities.
    Boutselis JG, Ullery JC, Pace W.
    Ohio State Med J; 1971 Aug 21; 67(8):721-5. PubMed ID: 4105456
    [No Abstract] [Full Text] [Related]

  • 12. A discussion of the results of chemotherapy on gynecological cancer and the host's immune response.
    Trelford JD.
    Proc Natl Cancer Conf; 1970 Aug 21; 6():365-85. PubMed ID: 5458106
    [No Abstract] [Full Text] [Related]

  • 13. [Proliferative kinetics of human genital carcinoma following the action of cytostatics and hormones in in vivo tests].
    Heckmann U, Hamann A, Inamoto E.
    Zentralbl Gynakol; 1969 Aug 16; 91(33):1057-61. PubMed ID: 5368199
    [No Abstract] [Full Text] [Related]

  • 14. Chemotherapy in gynecologic cancer.
    Smith JP.
    Clin Obstet Gynecol; 1975 Dec 16; 18(4):109-24. PubMed ID: 174855
    [No Abstract] [Full Text] [Related]

  • 15. Gynecologic cancers.
    Boente MP, Schilder R, Ozols RF.
    Cancer Chemother Biol Response Modif; 1997 Dec 16; 17():536-61. PubMed ID: 9551230
    [Abstract] [Full Text] [Related]

  • 16. [Ozone-oxygen injection in gynecological radiotherapy].
    Hernuss P, Müller-Tyl E, Dimopoulos J.
    Strahlentherapie; 1974 Sep 16; 148(3):242-5. PubMed ID: 4446040
    [No Abstract] [Full Text] [Related]

  • 17. [Experiences on in vitro testing of cytostatic sensitivity (oncobiogram) in gynecological tumors].
    Krafft W, Preibsche W, Marzotko F.
    Arch Geschwulstforsch; 1973 Sep 16; 41(3):241-7. PubMed ID: 4732846
    [No Abstract] [Full Text] [Related]

  • 18. [In vitro testing and clinical experience with 5-fluorouracil in gynaecologic cancer (author's transl)].
    Marzotko F, Krafft W, Preibsch W, Schröder M.
    Arch Geschwulstforsch; 1976 Sep 16; 46(2):140-5. PubMed ID: 962505
    [Abstract] [Full Text] [Related]

  • 19. [Adjuvant cytostatic chemotherapy in gynecologic tumors].
    Schildknecht O, Senn HJ.
    Haematol Blood Transfus; 1978 Sep 16; 22():155-64. PubMed ID: 220153
    [No Abstract] [Full Text] [Related]

  • 20. Distribution of some inherited blood characters, changes in fifth fraction of serum lactate dehydrogenase, and resistance to cytembena in women with gynaecological carcinoma.
    Milunicová A, Jandová A, Skoda V.
    Neoplasma; 1971 Sep 16; 18(2):219-24. PubMed ID: 5577318
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.